This is in line with the results of the study of de Torres and co-workers who postulated that, particularly in patients with moderate to severe COPD, the magnitude of CRP-levels could be critically influenced by other factors such as morbidity (cardiovascular disease, metabolic syndrome, hypertension etc.), degree of physical activity, diet, smoking status and medications [58]. The gene discussed is CRP; the disease is metabolic syndrome.